XML 60 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2013
SEGMENT INFORMATION [Abstract]  
Segment Reporting Information, by Segment
The Company’s reportable segments are strategic businesses that offer products and services to different markets. The Company presently has three segments: Specialty Products; Food, Pharma & Nutrition; and Animal Nutrition & Health. The Specialty Products segment provides specialty-packaged chemicals for use in healthcare and other industries. Human choline nutrient products, pharmaceutical products and encapsulated products are reported in the Food, Pharma & Nutrition segment. This segment provides microencapsulation solutions to a variety of applications in food, pharmaceutical and nutritional ingredients to enhance performance of nutritional fortification, processing, mixing, packaging applications and shelf-life. The Animal Nutrition & Health segment manufactures and supplies choline chloride, an essential nutrient for animal health, to the poultry and swine industries. In addition, certain derivatives of choline chloride are manufactured and sold into industrial applications and are included in this segment. Chelated minerals and specialty nutritional products for the animal health industry are also reported in this segment. The Company sells products for all segments through its own sales force, independent distributors, and sales agents. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.

Business Segment Net Sales:
 
 
2013
  
2012
  
2011
 
Specialty Products
 
$
51,086
  
$
49,990
  
$
47,851
 
Food, Pharma & Nutrition
  
47,569
   
44,070
   
42,525
 
Animal Nutrition & Health
  
238,518
   
216,333
   
201,491
 
Total
 
$
337,173
  
$
310,393
  
$
291,867
 

Business Segment Earnings Before Income Taxes:
 
 
2013
  
2012
  
2011
 
Specialty Products
 
$
20,224
  
$
20,332
  
$
18,636
 
Food, Pharma & Nutrition
  
11,233
   
11,335
   
11,113
 
Animal Nutrition & Health
  
34,145
   
28,110
   
26,476
 
Interest and other income, net
  
216
   
67
   
513
 
Total
 
$
65,818
  
$
59,844
  
$
56,738
 

Depreciation/Amortization:
 
 
2013
  
2012
  
2011
 
Specialty Products
 
$
1,386
  
$
1,369
  
$
1,291
 
Food, Pharma & Nutrition
  
1,356
   
1,444
   
1,486
 
Animal Nutrition & Health
  
7,732
   
6,828
   
6,514
 
Total
 
$
10,474
  
$
9,641
  
$
9,291
 

Business Segment Assets:
 
 
2013
  
2012
  
2011
 
Specialty Products
 
$
24,850
  
$
26,964
  
$
25,618
 
Food, Pharma & Nutrition
  
22,343
   
21,393
   
20,307
 
Animal Nutrition & Health
  
116,710
   
116,035
   
105,422
 
Other Unallocated
  
212,969
   
148,153
   
120,370
 
Total
 
$
376,872
  
$
312,545
  
$
271,717
 

Other unallocated assets consist of certain cash, receivables, prepaid expenses, equipment and leasehold improvements, net of accumulated depreciation, and deferred income taxes, which the Company does not allocate to its individual business segments.

Capital Expenditures:
 
 
2013
  
2012
  
2011
 
Specialty Products
 
$
725
  
$
836
  
$
1,034
 
Food, Pharma & Nutrition
  
1,318
   
924
   
403
 
Animal Nutrition & Health
  
6,144
   
12,123
   
5,175
 
Total
 
$
8,187
  
$
13,883
  
$
6,612
 
Geographic Revenue Information
Geographic Revenue Information:
 
 
2013
  
2012
  
2011
 
United States
 
$
227,651
  
$
207,490
  
$
191,204
 
Foreign Countries
  
109,522
   
102,903
   
100,663
 
Total
 
$
337,173
  
$
310,393
  
$
291,867
 
Geographic area data - long-lived assets (excluding intangible assets)
Geographic Area Data – Long-Lived Assets (excluding intangible assets):
 
 
2013
  
2012
  
2011
 
United States
 
$
43,078
  
$
41,183
  
$
33,511
 
Italy
  
11,838
   
11,542
   
10,771
 
Total
 
$
54,916
  
$
52,725
  
$
44,282